MAPT and Alzheimer disease: Early rs-fMRI studies focused on the hippocampus [104], because amyloidosis and tau pathology initially appear in the hippocampus [105,106,107], and hippocampal volume loss during the progression of AD is directly associated with cognitive decline in longitudinal studies [108,109].